ClinicalTrials.Veeva

Menu

Aortic Balloon Counterpulastion in Myocardial Infarction Related Shock (IABPSHOCK)

M

Martin-Luther-Universität Halle-Wittenberg

Status

Completed

Conditions

Myocardial Infarction
Cardiogenic Shock

Treatments

Device: Intra-aortic balloon pump counterpulsation

Study type

Interventional

Funder types

Other

Identifiers

NCT00469248
MLU-IABPSHOCK

Details and patient eligibility

About

The role of intra aortic balloon counterpulsation in patients experiencing acute myocardial infarction with shock is not established. We hypothesised that use of such a device would lead to improved outcomes in these patients.

Full description

Patients undergoing percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) with cardiogenic shock (CS) are often treated with Intra-aortic balloon pump counterpulsation (IABP) although the evidence to support this is limited. We conducted a prospective, randomised clinical trial, of IABP as an addition to PCI centred therapy, in patients with AMI complicated by CS.

45 patients with AMI and CS undergoing PCI were randomised to care with or without IABP. Over 4 days, APACHE II scores, haemodynamic parameters, inflammatory markers and BNP levels were collected to assess the impact of IABP treatment on CS triggered multi organ dysfunction syndrome (MODS).

Enrollment

45 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Acute myocardial infarction
  • Cardiogenic shock

Exclusion criteria

  • Absent peripheral pulses
  • Mechanical complications of myocardial infarction

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems